Bora Pharmaceuticals Co., Ltd./ADR

Bora Pharmaceuticals (BORAY) shows no detected cyber incidents or red-flag 8-K filings in the past 90 days, suggesting operational stability in our recent monitoring window. However, the absence of near-term signals does not eliminate structural risks—particularly dilution exposure and historical financing patterns that warrant deeper analysis. The full $49 Report extends the lookback to 12 months, layers in dilution risk scoring, financing history, and AI-detected risk signals that may not surface in routine filings. The full $49 Report adds quantified shareholder dilution risk, comprehensive 12-month event context, and predictive risk flagging across capital structures and officer activity.